Cargando…

Exploration of Potential Roles of a New LOXL2 Splicing Variant Using Network Knowledge in Esophageal Squamous Cell Carcinoma

LOXL2 (lysyl oxidase-like 2), an enzyme that catalyzes oxidative deamination of lysine residue, is upregulated in esophageal squamous cell carcinoma (ESCC). A LOXL2 splice variant LOXL2-e13 and its wild type were overexpressed in ESCC cells followed by microarray analyses. In this study, we explored...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Bing-Li, Lv, Guo-Qing, Zou, Hai-Ying, Du, Ze-Peng, Wu, Jian-Yi, Zhang, Pi-Xian, Xu, Li-Yan, Li, En-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165399/ https://www.ncbi.nlm.nih.gov/pubmed/25254241 http://dx.doi.org/10.1155/2014/431792

Ejemplares similares

A three‐gene signature from protein–protein interaction network of LOXL2‐ and actin‐related proteins for esophageal squamous cell carcinoma prognosis
por: Zhan, Xiu‐hui, et al.
Publicado: (2017)

LncRNA LOXL1-AS1 promotes esophageal squamous cell carcinoma progression by targeting DESC1
por: Li, Hongle, et al.
Publicado: (2021)

Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1
por: Pasutto, Francesca, et al.
Publicado: (2017)

Redox Potentials of Disulfide Bonds in LOXL2 Studied by Nonequilibrium Alchemical Simulation
por: Lin, Lirui, et al.
Publicado: (2021)

Functional analysis of the mRNA profile of neutrophil gelatinase-associated lipocalin overexpression in esophageal squamous cell carcinoma using multiple bioinformatic tools
por: WU, BING-LI, et al.
Publicado: (2014)

Desmocollin-2 affects the adhesive strength and cytoskeletal arrangement in esophageal squamous cell carcinoma cells
por: FANG, WANG-KAI, et al.
Publicado: (2014)

The effect of LOXL2 in hepatocellular carcinoma
por: Wu, Linghong, et al.
Publicado: (2016)

LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression()
por: Jiao, Ji-Wei, et al.
Publicado: (2022)

LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung
por: Ma, Hsiao-Yen, et al.
Publicado: (2023)

LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
por: Shao, Bing, et al.
Publicado: (2018)

Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development
por: Santamaría, Patricia G., et al.
Publicado: (2022)

DASES: a database of alternative splicing for esophageal squamous cell carcinoma
por: Chen, Yilong, et al.
Publicado: (2023)

Mass cytometry and transcriptomic profiling reveal body‐wide pathology induced by Loxl1 deficiency
por: Li, Yu, et al.
Publicado: (2021)

LOXL1 gene variants and their association with pseudoexfoliation glaucoma (XFG) in Spanish patients
por: Álvarez, Lydia, et al.
Publicado: (2015)

Structural, functional and molecular pathogenesis of pelvic organ prolapse in patient and Loxl1 deficient mice
por: Li, Yu, et al.
Publicado: (2021)

Analysis of LOXL1 gene variants in Japanese patients with branch retinal vein occlusion
por: Hara, Katsunori, et al.
Publicado: (2011)

Common sequence variants in the LOXL1 gene in pigment dispersion syndrome and pigmentary glaucoma
por: Giardina, Emiliano, et al.
Publicado: (2014)

Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma
por: Sahebi, Reza, et al.
Publicado: (2016)

Identification of the involvement of LOXL4 in generation of keratocystic odontogenic tumors by RNA-Seq analysis
por: Jiang, Wei-Peng, et al.
Publicado: (2014)

Significance of HIF-1α Expression and LOXL-2 Localization in Progression of Oral Squamous Cell Carcinoma
por: Bharti, Anshul, et al.
Publicado: (2021)

Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2014)

LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC
por: Yuan, Ruiyan, et al.
Publicado: (2021)

Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese
por: Lee, Kelvin Y.C., et al.
Publicado: (2009)

LOXL2 as a protective in osteoarthritis cartilage
por: Bais, Manish V., et al.
Publicado: (2017)

Linking LOXL2 to Cardiac Interstitial Fibrosis
por: Erasmus, Melisse, et al.
Publicado: (2020)

LOXL2 Inhibitors and Breast Cancer Progression
por: Ferreira, Sandra, et al.
Publicado: (2021)

A novel genetic variant associated with benign paroxysmal positional vertigo within the LOXL1
por: Deng, Mingzhu, et al.
Publicado: (2020)

Possible Protective Effect of LOXL1 Variant in the Cohort of Chernobyl Catastrophe Clean-Up Workers
por: Žukauskaitė, Gabrielė, et al.
Publicado: (2021)

A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer
por: Xia, Qiaoxi, et al.
Publicado: (2023)

Cleavage of LOXL1 by BMP1 and ADAMTS14 Proteases Suggests a Role for Proteolytic Processing in the Regulation of LOXL1 Function
por: Rosell-García, Tamara, et al.
Publicado: (2022)

Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target
por: Xiong, Xiao, et al.
Publicado: (2020)

LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT
por: Zhang, Qing, et al.
Publicado: (2020)

LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling
por: Zhang, Caixia, et al.
Publicado: (2021)

N6‐methyladenosine reader YTHDF3 regulates melanoma metastasis via its ‘executor'LOXL3
por: Shi, Hao‐ze, et al.
Publicado: (2022)

LOXL 2 Promotes The Epithelial–Mesenchymal Transition And Malignant Progression Of Cervical Cancer
por: Tian, Jing, et al.
Publicado: (2019)

Increased serum LOXL2 concentration in pelvic inflammatory disease with pelvic adhesion
por: Xie, Chan, et al.
Publicado: (2022)

LOXL2—A New Target in Antifibrogenic Therapy?
por: Puente, Angela, et al.
Publicado: (2019)

Wnt signaling and Loxl2 promote aggressive osteosarcoma
por: Matsuoka, Kazuhiko, et al.
Publicado: (2020)

LAMA2 and LOXL4 are candidate FSGS genes
por: Vijayan, Poornima, et al.
Publicado: (2021)

LOXL2 in Cancer: A Two-Decade Perspective
por: Cano, Amparo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_16is9drth7qokcv02nt4ndbbb5